Yeon-Mi Ryu Selected Research

Neoplasms (Cancer)

2/2023	Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer.
5/2022	Immune Profile of BRAF-Mutated Metastatic Colorectal Tumors with Good Prognosis after Palliative Chemotherapy.
4/2022	Double Ki-67 and synaptophysin labeling in pancreatic neuroendocrine tumor biopsies.
1/2022	Comprehensive evaluation of the tumor immune microenvironment and its dynamic changes in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy: From the phase II ADORE study.
1/2022	Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment.
10/2021	siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model.
1/2021	Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer.
2/2019	Increased nicotinamide adenine dinucleotide pool promotes colon cancer progression by suppressing reactive oxygen species level.
1/2019	Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes.
12/2018	Multiplexed In Vivo Imaging Using Size-Controlled Quantum Dots in the Second Near-Infrared Window.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yeon-Mi Ryu Research Topics

Disease

17	Neoplasms (Cancer) 02/2023 - 05/2011
6	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 08/2013
6	Carcinogenesis 12/2018 - 04/2013
4	Colonic Neoplasms (Colon Cancer) 02/2019 - 11/2010
3	Adenoma (Adenomas) 01/2017 - 08/2013
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 02/2023 - 01/2021
2	Adenocarcinoma 12/2018 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 12/2018 - 05/2011
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Disease Progression 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021
1	Reperfusion Injury 10/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2016
1	Colitis 08/2016
1	Multiple Primary Neoplasms 08/2013
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2013
1	Infections 04/2013
1	Gastritis 05/2011
1	Osteoporosis 03/2006

Drug/Important Bio-Agent (IBA)

6	15-hydroxyprostaglandin dehydrogenaseIBA 12/2018 - 05/2011
2	Cisplatin (Platino)FDA LinkGeneric 02/2023 - 01/2021
2	Gemcitabine FDA Link 02/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 02/2019 - 08/2013
2	Dinoprostone (PGE2)FDA Link 12/2018 - 01/2017
2	Molecular Probes (Molecular Probe)IBA 02/2017 - 05/2014
1	Cadherins (E-Cadherin)IBA 02/2023
1	VimentinIBA 02/2023
1	Keratins (Keratin)IBA 05/2022
1	Calcibiotic Root Canal SealerIBA 05/2022
1	Combined Antibody TherapeuticsIBA 04/2022
1	SynaptophysinIBA 04/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	NivolumabIBA 01/2022
1	IpilimumabIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	OvalbuminIBA 10/2021
1	AntigensIBA 10/2021
1	Small Interfering RNA (siRNA)IBA 10/2021
1	Granzymes (Granzyme)IBA 10/2021
1	Nicotinamide PhosphoribosyltransferaseIBA 02/2019
1	Dextrans (Dextran)FDA Link 02/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2019
1	NAD (NADH)IBA 02/2019
1	AzoxymethaneIBA 02/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	EnzymesIBA 12/2018
1	MicroRNAs (MicroRNA)IBA 12/2018
1	LigandsIBA 12/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2018
1	PhosphatidylserinesIBA 08/2018
1	Peptides (Polypeptides)IBA 08/2018
1	Fluorescein-5-isothiocyanate (FITC)IBA 02/2017
1	Heavy MetalsIBA 02/2017
1	Prostaglandin-E SynthasesIBA 01/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	ProstaglandinsIBA 01/2017
1	Fluorescent Dyes (Fluorescent Probes)IBA 08/2016
1	balsalazide (Colazal)FDA LinkGeneric 08/2016
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 08/2016
1	Matrix Metalloproteinases (MMPs)IBA 05/2014
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2013
1	Oxidoreductases (Dehydrogenase)IBA 09/2013
1	Messenger RNA (mRNA)IBA 08/2013
1	ErbB Receptors (EGF Receptor)IBA 04/2013
1	CateninsIBA 11/2010
1	Estrogens (Estrogen)FDA Link 03/2006

Therapy/Procedure

3	Quantum Dots (Quantum Dot) 02/2017 - 05/2014
2	Drug Therapy (Chemotherapy) 05/2022 - 08/2018
1	Chemoradiotherapy 01/2022
1	Immunotherapy 10/2021
1	Therapeutics 10/2019
1	Radiotherapy 08/2018
1	Chemoprevention 08/2016
1	Endoscopes 05/2014